Edward Morrow Atkinson III, EVP, Chief Technical Operations Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 5,190 shares at $480.95 ($2.5M) on 2025-02-25, disclosed to the SEC on 2025-02-26.
Scheduled sale ($2.5M) by EVP, Chief Technical Operations Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $483.28 | 1,656 | $800K | 32.0% |
| 2 | $480.95 | 1,767 | $850K | 34.0% |
| 3 | $480.95 | 1,767 | $850K | 34.0% |
| Total | $481.69 avg | 5,190 | $2.5M | 100% |
| Filing → |
| VRTX | SELL | 2026-02-12 | $806K | — | Filing → |
| VRTX | SELL | 2025-11-19 | $1.1M | — | Filing → |
| VRTX | SELL | 2025-02-28 | $1.3M | — | Filing → |